iBio, Inc. IBIO
NASDAQ IBIO
$1.12 +0.01 (+0.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

iBio (IBIO) Non Operating Investment Income (2013 - 2024)

Updated

iBio (IBIO) reported Non Operating Investment Income of $1 million for FY2024 (year ended Jun 30, 2024).

Analysis

iBio (IBIO) Non Operating Investment Income (2013 - 2024) Analysis & Trends

  • The FY2024 figure ranks as the lowest annual Non Operating Investment Income since FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Op. Investment Inc. (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn -
10 iBio 116.55 Mn 116.55 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1.00 Mn
Mar 31, 2014 3,000.00
Dec 31, 2013 -1,000.00
API Access

iBio Non Operating Investment Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=IBIO&period=max&api_key=YOUR_API_KEY